Liu et al. observed SNPs in P53 (rs1042522) and MDM2 (rs2279744) in 199 patients with stage III – IV non-small cell lung cancer who were undergoing cisplatin-based chemotherapy34. This evidence concerns the gene TP53 and non-small cell lung carcinoma.